Globus Medical, Inc. GMED
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -23.39%
- 1 year
- -18.70%
Held by funds
205 US ETFs and mutual funds hold GMED · largest positions
- NJH 0.25% of fund $288.86M
- IJH 0.24% of fund $284.37M
- VTI 0.01% of fund $222.05M
- VB 0.11% of fund $197.06M
- VBK 0.26% of fund $110.35M
- VXF 0.11% of fund $98.98M
- DFAT 0.27% of fund $82.69M
- VVORX 0.71% of fund $72.26M
- MDY 0.24% of fund $59.18M
- NNK 0.47% of fund $51.81M
- VMCCX 3.03% of fund $51.16M
- IJK 0.48% of fund $48.74M
- SPMD 0.24% of fund $43.41M
- DFAS 0.13% of fund $43.18M
- VEXRX 0.19% of fund $42.45M
- SCHA 0.20% of fund $41.27M
- IHI 1.00% of fund $39.78M
- KMD 1.33% of fund $39.31M
- FSMAX 0.10% of fund $38.55M
- XOVR 2.97% of fund $36.41M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.91% | 10,906,047 | 729.45M | Sep 29, 2026 |
| Janus Henderson Group Ltd. | 7.85% | 8,634,195 | 577.50M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.61% | 5,075,559 | 339.48M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 4.42% | 4,866,366 | 325.49M | Sep 29, 2026 |
| State Street Corporation | 3.38% | 3,718,553 | 248.72M | Sep 29, 2026 |
| Boston Partners | 3.10% | 3,415,554 | 228.45M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.62% | 3,983,485 | 266.44M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.27% | 3,595,564 | 240.49M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.36% | 2,597,815 | 173.75M | Jun 29, 2026 |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 2.10% | 2,313,088 | 154.71M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.36% | 1,496,500 | 100.09M | Jun 29, 2026 |
| J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd. | 1.34% | 1,475,978 | 98.72M | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs GMED, and what each was last paid
Keith W. Pfeil, Chief Executive Officer, President & DirectorAverage age 52
| Name | Title | Pay | Age |
|---|---|---|---|
| Keith W. Pfeil | Chief Executive Officer, President & Director | $1.42M | 47 |
| David C. Paul | Co-Founder & Executive Chairman | $1.62M | 59 |
| Kelly G. Huller | Executive Vice President, General Counsel & Corporate Secretary | $850K | 54 |
| Kyle R. Klin | Senior Vice President & Chief Financial Officer | $617K | 40 |
| Brian J. Kearns | Senior Vice President of Business Development & Investor Relations | — | 59 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DAVIDAR DAVID D | Director | Stock Gift | Jul 26, 2026 | 673,642 |
| KLINE KYLE | Chief Financial Officer | Sale | Jan 7, 2026 | 0 |
| LEMAITRE DANIEL | Director | Sale | Nov 21, 2024 | 0 |
| NORWALK LESLIE V | Director | Sale | Jan 7, 2026 | 10,419 |
| PAUL DAVID C | Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security | Dec 7, 2025 | 60,417 |
| PFEIL KEITH W. | Chief Operating Officer | Sale | Jan 9, 2025 | 0 |
